BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 11606408)

  • 21. Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-hodgkin's lymphoma patients mobilized with different growth factors.
    Gazitt Y; Shaughnessy P; Liu Q
    Stem Cells; 2001; 19(2):134-43. PubMed ID: 11239168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
    Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
    Hirai M; LaFace D; Robinson S; Kelsey L; Johnson R; Wen SF; Warkentin P; Mills K; Vaillancourt M; Chavez J; Leutzinger C; Sumegi J; Neugebauer S; Lehman J; Talmadge C; Maneval D; Talmadge J
    Cancer Gene Ther; 2001 Dec; 8(12):936-47. PubMed ID: 11781656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
    Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
    Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors.
    Rafii S; Heissig B; Hattori K
    Gene Ther; 2002 May; 9(10):631-41. PubMed ID: 12032709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
    Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
    Delamain MT; Metze K; Marques JF; Reis AR; De Souza CA; Lorand-Metze I
    Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
    Shekhar MP; Werdell J; Tait L
    Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOXB7: a key factor for tumor-associated angiogenic switch.
    Carè A; Felicetti F; Meccia E; Bottero L; Parenza M; Stoppacciaro A; Peschle C; Colombo MP
    Cancer Res; 2001 Sep; 61(17):6532-9. PubMed ID: 11522651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
    Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
    Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
    Isidori A; Tani M; Bonifazi F; Zinzani P; Curti A; Motta MR; Rizzi S; Giudice V; Farese O; Rovito M; Alinari L; Conte R; Baccarani M; Lemoli RM
    Haematologica; 2005 Feb; 90(2):225-31. PubMed ID: 15710576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
    Pelus LM; Fukuda S
    Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
    Yonou H; Kanomata N; Goya M; Kamijo T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2003 May; 63(9):2096-102. PubMed ID: 12727825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells.
    McKenzie JL; Gan OI; Doedens M; Dick JE
    Exp Hematol; 2007 Sep; 35(9):1429-36. PubMed ID: 17656009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.